# Ardent Health, Inc.: overview

ARDT · NYSE · CIK 1756655 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ardt.md) · [Financials](/companies/ardt/financials.md) · [Filings](/companies/ardt/filings.md) · [Insiders](/companies/ardt/insiders.md)

Latest reported revenue: [$1.62bn](/filings/0001628280-26-055215.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-055215).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,450](/filings/0001628280-25-052362.md) | [1,606 d](/filings/0001628280-26-018174.md) | [1,497](/filings/0001628280-26-031299.md) | [1,645](/filings/0001628280-26-055215.md) | [1,577](/filings/0001628280-25-052362.md) | [1,605 d](/filings/0001628280-26-018174.md) | [1,602](/filings/0001628280-26-031299.md) | [1,622](/filings/0001628280-26-055215.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [1.8%](/filings/0001628280-25-052362.md) | [7.1% d](/filings/0001628280-26-018174.md) | [2.8%](/filings/0001628280-26-055215.md) | [4.4%](/filings/0001628280-26-055215.md) | [(1.5%)](/filings/0001628280-25-052362.md) | [2.8% d](/filings/0001628280-26-018174.md) | [2.5%](/filings/0001628280-26-055215.md) | [1.0%](/filings/0001628280-26-055215.md) |
| Diluted EPS | $ per share | [0.19](/filings/0001628280-25-052362.md) | not reported | [0.29](/filings/0001628280-26-031299.md) | [0.52](/filings/0001628280-26-055215.md) | [(0.17)](/filings/0001628280-25-052362.md) | not reported | [0.28](/filings/0001628280-26-031299.md) | [0.12](/filings/0001628280-26-055215.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2022-12-31) | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,130](/filings/0001628280-25-008727.md) | [5,409](/filings/0001628280-26-018174.md) | [5,966](/filings/0001628280-26-018174.md) | [6,324](/filings/0001628280-26-018174.md) |
| Gross margin | % | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported |
| Net margin | % | [3.7%](/filings/0001628280-25-008727.md) | [1.0%](/filings/0001628280-26-018174.md) | [3.5%](/filings/0001628280-26-018174.md) | [2.1%](/filings/0001628280-26-018174.md) |
| Diluted EPS | $ per share | [1.50](/filings/0001628280-25-008727.md) | [0.43](/filings/0001628280-26-018174.md) | [1.58](/filings/0001628280-26-018174.md) | [0.96](/filings/0001628280-26-018174.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ardt/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [CHAI TRUST CO LLC](/funds/1250731.md) | 2026-06-30 | $760.1m | 77,246,499 |  | Unchanged |
| [Ventas, Inc.](/funds/740260.md) | 2026-06-30 | $91.9m | 9,342,501 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $21.4m | 2,176,348 |  | Added +418,133 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $20.8m | 2,110,599 |  | Added +333,873 |
| [GOLDENTREE ASSET MANAGEMENT LP](/funds/1278951.md) | 2026-06-30 | $15.5m | 1,580,423 |  | Reduced −722,690 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $14.2m | 1,447,810 |  | Added +505,457 |
| [CastleKnight Management LP](/funds/1835751.md) | 2026-06-30 | $10.6m | 1,076,967 |  | Unchanged |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $9.5m | 963,833 |  | Reduced −44,605 |
| [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $8.3m | 841,126 |  | Reduced −89,542 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $6.1m | 620,947 |  | Added +59,504 |

## Recent filings

[All 173 filings](/companies/ardt/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:42 ET | [8-K](/filings/0001104659-26-118499.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-118499 |
| 2026-09-04 | 16:16 ET | [8-K](/filings/0001628280-26-060735.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-060735 |
| 2026-08-10 | 16:07 ET | [10-Q](/filings/0001628280-26-055215.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055215 |
| 2026-08-04 | 16:16 ET | [8-K](/filings/0001628280-26-052598.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052598 |
| 2026-06-30 | 16:33 ET | [8-K](/filings/0001628280-26-046247.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-046247 |
| 2026-06-02 | 16:23 ET | [8-K](/filings/0001193125-26-253567.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-253567 |
| 2026-05-26 | 16:37 ET | [8-K](/filings/0001628280-26-038152.md) | 5.07 Shareholder vote results | 0001628280-26-038152 |
| 2026-05-06 | 16:19 ET | [10-Q](/filings/0001628280-26-031299.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031299 |
| 2026-05-05 | 16:15 ET | [8-K](/filings/0001628280-26-030552.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030552 |
| 2026-04-08 | 16:17 ET | [DEF 14A](/filings/0001628280-26-024244.md) | Proxy statement, period 2026-05-20 | 0001628280-26-024244 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-018174.md), filed Mar 16, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/5734e072-3334-4636-975f-b8542400fda0)

## About the filer

- CIK: 1756655
- Tickers: ARDT
- Exchange: NYSE
- SIC code: 8062 Services-General Medical & Surgical Hospitals, NEC
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.